The corporation has offices in the US, India, and Hong Kong. India Globalization Capital, Inc. is situated in Potomac, Maryland, and was founded in 2005. ... read more
The United States Patent and Trademark Office ("USPTO") granted India Globalization Capital, Inc. (the "Company") (NYSE American: IGC) another patent (patent#10,933,082) for the Company's cannabinoid composition and method for treating pain in patients with Psoriatic Arthritis, Fibromyalgia, Scleroderma, and other conditions on March 2, 2021.
Newest patent approval
On October 1, 2018, the patent application was submitted. The newest patent approval complements the Company's current patent portfolio, which includes USPTO patents for seizure disorders and eating disorders.
IGC is divided into two divisions: infrastructure and life sciences. The headquarters of the company are in Potomac, Maryland, United States of America.
Richard K. Prins
Independent Chairman of the Board
Vice President, Principal Financial Officer
John E. Lynch